🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is a Phase III non-inferiority trial targeting a specific subset...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-03-31
Trial ID
NCT07432178
Treatments Being Tested
Prospective, multi-center, randomized, open label comparative Phase III stu...
Status
Recruiting
Location
University Clinic Ulm
Start Date
2025-04-22
Trial ID
NCT06643585
Treatments Being Tested
This trial is a registrational Phase III, randomized, open-label, multicent...
Status
Recruiting
Location
Beijing Cancer Hospital
Start Date
2026-06-29
Trial ID
NCT07582315
Determine whether viagenpumatucel-L combined with low-dose cyclophosphamide...
Status
Terminated
Location
Highlands Oncology Group
Start Date
2014-07
Trial ID
NCT02117024
Comparison of olaparib vs. physician's choice of single agent standard of c...
Status
Completed
Location
Research Site
Start Date
2015-02-06
Trial ID
NCT02282020
Treatments Being Tested
This ALCHEMIST trial studies genetic testing in screening patients with sta...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2014-09-26
Trial ID
NCT02194738
Treatments Being Tested
This is a 2-arm parallel pragmatic randomized controlled trial that will co...
Status
Completed
Location
Jaseng Hospital of Korean Medicine
Start Date
2021-07-09
Trial ID
NCT04833270
Treatments Being Tested
This is a prospective, randomized, open-label, multicenter phase III study ...
Status
Recruiting
Location
Zhimin Cancer Shao
Start Date
2024-04-02
Trial ID
NCT06341621
Treatments Being Tested
This study is a multicenter, prospective, randomized controlled Phase II cl...
Status
Not Yet Recruiting
Location
Beijing Cancer Hospital, 52 Fucheng Road
Start Date
2025-07-30
Trial ID
NCT06772233
Treatments Being Tested
This study will compare how safe and effective sacituzumab tirumotecan is v...
Status
Active Not Recruiting
Location
Banner MD Anderson Cancer Center ( Site 0119)
Start Date
2024-05-03
Trial ID
NCT06356311